Literature DB >> 20075205

The vanguard has arrived in the clinical laboratory: array-based karyotyping for prognostic markers in chronic lymphocytic leukemia.

Shelly R Gunn1.   

Abstract

This Commentary provides a state of the art for array-based karyotyping in cancer diagnostics.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20075205      PMCID： PMC2871719          DOI： 10.2353/jmoldx.2010.090203

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN： 1525-1578            Impact factor:   5.568


  16 in total

Review 1.  Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL.

Authors:  Tait D Shanafelt; Susan M Geyer; Neil E Kay
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

2.  Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.

Authors:  Carsten Schwaenen; Michelle Nessling; Swen Wessendorf; Tatjana Salvi; Gunnar Wrobel; Bernhard Radlwimmer; Hans A Kestler; Christian Haslinger; Stephan Stilgenbauer; Hartmut Döhner; Martin Bentz; Peter Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-16       Impact factor: 11.205

3.  An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

Authors:  Xiaojun Zhao; Cheng Li; J Guillermo Paez; Koei Chin; Pasi A Jänne; Tzu-Hsiu Chen; Luc Girard; John Minna; David Christiani; Chris Leo; Joe W Gray; William R Sellers; Matthew Meyerson
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 4.  Array comparative genomic hybridization and its applications in cancer.

Authors:  Daniel Pinkel; Donna G Albertson
Journal:  Nat Genet       Date:  2005-06       Impact factor: 38.330

5.  Molecular diagnosis of ewing family tumors: too many fusions... ?

Authors:  Frederic G Barr; Richard B Womer
Journal:  J Mol Diagn       Date:  2007-07-25       Impact factor: 5.568

6.  Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.

Authors:  Ankita Patel; Sung-Hae Kang; Patrick Alan Lennon; Yin Feng Li; P Nagesh Rao; Lynne Abruzzo; Chad Shaw; Alan Craig Chinault; Sau W Cheung
Journal:  Am J Hematol       Date:  2008-07       Impact factor: 10.047

Review 7.  Chromosomal abnormalities in cancer.

Authors:  Stefan Fröhling; Hartmut Döhner
Journal:  N Engl J Med       Date:  2008-08-14       Impact factor: 91.245

8.  Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia.

Authors:  Shelly R Gunn; Mansoor S Mohammed; Mercedes E Gorre; Philip D Cotter; Jaeweon Kim; David W Bahler; Sergey N Preobrazhensky; Russell A Higgins; Aswani R Bolla; Sahar H Ismail; Daphne de Jong; Eric Eldering; Marinus H J van Oers; Clemens H M Mellink; Michael J Keating; Ellen J Schlette; Lynne V Abruzzo; Ryan S Robetorye
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

Review 9.  Whole genome scanning as a cytogenetic tool in hematologic malignancies.

Authors:  Jaroslaw P Maciejewski; Ghulam J Mufti
Journal:  Blood       Date:  2008-05-27       Impact factor: 22.113

10.  The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.

Authors:  Armand B Glassman; Kimberly J Hayes
Journal:  Cancer Genet Cytogenet       Date:  2005-04-01
View more
  3 in total

1.  Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.

Authors:  Shelly Gunn; I-Tien Yeh; Irina Lytvak; Budi Tirtorahardjo; Natasha Dzidic; Soheila Zadeh; Jaeweon Kim; Chris McCaskill; Lony Lim; Mercedes Gorre; Mansoor Mohammed
Journal:  BMC Cancer       Date:  2010-07-28       Impact factor: 4.430

2.  Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer.

Authors:  Shelly Gunn; Xavier Reveles; Korrie Weldon; Andres Barrera; Mariam Ishaque; Dale Taylor; Chris McCaskill; Jaeweon Kim; Rashmi Shah; Mansoor Mohammed; Todd Barry; Brianne Kaiser; Amita Patnaik; Anthony Tolcher
Journal:  J Ovarian Res       Date:  2013-01-04       Impact factor: 4.234

Review 3.  Not All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation Detection.

Authors:  Phillip N Gray; Charles L M Dunlop; Aaron M Elliott
Journal:  Cancers (Basel)       Date:  2015-07-17       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.